EcoR1 Capital’s Eloxx Pharmaceuticals ELOX Stock Holding History
Bought
Maintained
Sold
Other funds holding ELOX
SL
EcoR1 Capital's ELOX Position: Q3 2026 in Review
EcoR1 Capital held its Eloxx Pharmaceuticals (ELOX) position steady in Q3 2026 at 400,000 shares worth $6.12M. The position accounts for 0.27% of the portfolio, ranked #29.
EcoR1 Capital first reported a position in ELOX in Q2 2026 and has held it in 2 quarters since. 20 funds tracked by Wall St. Rank hold ELOX as of Q3 2026.
- EcoR1 Capital held 400,000 shares of Eloxx Pharmaceuticals worth $6.12M as of Q3 2026.
- EcoR1 Capital left its Eloxx Pharmaceuticals share count unchanged in Q3 2026.
- Eloxx Pharmaceuticals made up 0.27% of EcoR1 Capital's portfolio in Q3 2026, its #29 holding.
- EcoR1 Capital first reported a position in Eloxx Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
- 20 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals as of Q3 2026.
Based on EcoR1 Capital's 13F filing for Q3 2026, filed 16 Nov 2026.